FMO5 and chronic granulomatous disease: Numerous reports demonstrating a high prevalence of BCG complications and TB risk in chronic granulomatous disease provide a strong rationale for the critical role of NADPH oxidase in controlling TB in humans9, 10, 11, 12, 13.